Service agreement
Ended Awarded Last action
- Contract number
- 75N91024F90014
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7 Part of Thermo Electron Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,045
Award facts
- Contract value 100% obligated
- $12,045.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Life Technologies Corporation (doing business as Thermo Fisher Scientific) received a service agreement contract award from the National Cancer Institute on November 15, 2023, with an ultimate completion date of November 14, 2024. This Blanket Purchase Agreement (BPA) call, issued under a firm fixed-price contract type, carries a ceiling value of $12,045.04 and involves no set-aside designation. The work will be performed in Bethesda, Maryland, the location of the National Institutes of Health campus where NCI is headquartered. As a leading manufacturer of scientific instruments and reagents, Life Technologies is well-positioned to support NCI's research mission through the provision of specialized biotechnology products and laboratory services consistent with its existing federal contract portfolio.
The contract represents a task order or call against an existing BPA vehicle, leveraging Life Technologies' established relationships with federal research agencies. The company's parent entity, Thermo Electron Corporation, maintains significant indefinite delivery vehicles with various federal agencies, including a $9.5 million blanket purchase agreement with the Food and Drug Administration. Life Technologies' extensive experience supplying genetic analyzers, real-time PCR systems, flow cytometers, and related laboratory equipment to the National Institutes of Health and other federal research agencies demonstrates the contractor's capability to deliver the scientific instruments and services required to advance NCI's cancer research initiatives.
Quick answers
Who was awarded contract 75N91024F90014?
75N91024F90014 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on November 15, 2023.
How much is contract 75N91024F90014 worth?
The government has obligated $12,045 on 75N91024F90014.
Is contract 75N91024F90014 an order under another contract?
Yes. 75N91024F90014 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract 75N91024F90014 competed?
The extent of competition for 75N91024F90014 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award